Suspension from Quotation
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Vectus Biosystems Limited has requested a voluntary suspension of its securities from quotation on the ASX, effective immediately, pending an announcement regarding a material transaction related to its drug library. The suspension will remain in place until the earlier of the end of the requested period or the release of the announcement to the market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Vectus Biosystems Limited on 6ix
Earlier from Vectus Biosystems
- Trading Halt
- Pause in Trading
- Preliminary Final Report
- Agreement with C14 Consulting Group
- Passing of Vectus CEO
Later from Vectus Biosystems
- VB4-P5 Renal Compound Transaction
- Reinstatement to Quotation
- Response to ASX Query Letter
- Quarterly Activities & Appendix 4C Cash Flow Reports
- Half Year Report & Appendix 4D
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems